Skip to main content
Published locations for Dose reductions make ponatinib safer for CP-CML
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dose reductions make ponatinib safer for CP-CML
User login
Username
Password
Reset your password
/content/dose-reductions-make-ponatinib-safer-cp-cml
/hematology-oncology/article/188662/leukemia-myelodysplasia-transplantation/dose-reductions-make-ponatinib-safer
/hematologytimes/article/188662/leukemia-myelodysplasia-transplantation/dose-reductions-make